Skip to main content
Clinical Trials/NCT02076464
NCT02076464
Completed
Not Applicable

Using Technology to Improve Eating Disorders Treatment

Washington University School of Medicine0 sites690 target enrollmentJanuary 12, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eating Disorders
Sponsor
Washington University School of Medicine
Enrollment
690
Primary Endpoint
Change in eating disorder symptoms
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose is to evaluate a technologically-enhanced, guided self-help program to reduce eating disorder outcomes in college-age women.

Detailed Description

Colleges are faced with an elevated prevalence of eating disorders, yet less than 20% of students report receiving treatment. Inadequacies in mental health care delivery result in prolonged illness, disease progression, poorer prognosis, and greater likelihood of relapse, highlighting the need for improved modalities for screening and intervention. Over the past 20 years, we have developed a comprehensive, online platform through which we identify and offer tailored evidence-based interventions to individuals across the eating disorder risk and diagnostic spectrum, using minimal person-based resources. The newest intervention in our suite of programs, Student Bodies-Eating Disorders (SB-ED), has not yet been tested in a large-scale trial or via platform delivery. The aim of this study is to conduct the first national deployment of our comprehensive platform and demonstrate that our transdiagnostic guided self-help program, SB-ED, yields measurable and significant improvements in access, costs, and outcomes for eating disorder treatment over referral to usual care (i.e., treatment per protocol at students' corresponding college's mental health services center). Twenty-eight colleges will be randomly assigned to receive either SB-ED or referral to usual care. We will enroll at least 650 students from these campuses who screen positive for a DSM-5 clinical or subclinical eating disorder (excluding anorexia nervosa, which warrants more intensive medical monitoring). Outcomes will be measured at 6-months, 1-year, and 2-years following the completion of the online screen.

Registry
clinicaltrials.gov
Start Date
January 12, 2014
End Date
November 27, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Denise Wilfley

Principal Investigator

Washington University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Student at a participating college or university ages 18-30
  • Screen positive for DSM-5 bulimia nervosa, binge eating disorder, or a subclinical eating disorder

Exclusion Criteria

  • Screen positive for DSM-5 anorexia nervosa
  • No access to the internet
  • Acutely suicidal

Outcomes

Primary Outcomes

Change in eating disorder symptoms

Time Frame: Measured at baseline, 6-months, 1-year, and 2-years

Eating disorder outcomes will be measured using the Eating Disorder Examination Questionnaire

Secondary Outcomes

  • Comorbid symptom severity and impairment(2 years)
  • Realized treatment access(2 years)
  • Eating disorder behavior abstinence rates(2 years)
  • Service and implementation costs(up to 5 years)

Similar Trials